Logo image of NXP

NUVEEN SELECT TAX-FREE INC (NXP) Stock Price, Quote, News and Overview

NYSE:NXP - New York Stock Exchange, Inc. - US67062F1003 - Currency: USD

13.8  +0.04 (+0.29%)

Fundamental Rating

2

NXP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of NXP have multiple concerns. While showing a medium growth rate, NXP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXP had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: NXP reported negative net income in multiple years.
In the past 5 years NXP always reported negative operating cash flow.
NXP Yearly Net Income VS EBIT VS OCF VS FCFNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA 11.28%
ROE 11.52%
ROIC 3.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXP Yearly ROA, ROE, ROICNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 -6

1.3 Margins

NXP's Profit Margin has declined in the last couple of years.
NXP's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of NXP has remained more or less at the same level.
Industry RankSector Rank
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
OM growth 3Y1.18%
OM growth 5Y0.68%
PM growth 3Y-16.4%
PM growth 5Y-7.52%
GM growth 3Y0.36%
GM growth 5Y0.21%
NXP Yearly Profit, Operating, Gross MarginsNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for NXP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NXP Yearly Shares OutstandingNXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NXP Yearly Total Debt VS Total AssetsNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 30.16 indicates that NXP is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that NXP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 30.16
ROIC/WACCN/A
WACCN/A
NXP Yearly LT Debt VS Equity VS FCFNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.05 indicates that NXP should not have too much problems paying its short term obligations.
NXP has a Quick Ratio of 1.05. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NXP Yearly Current Assets VS Current LiabilitesNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 196.15% over the past year.
NXP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.91% yearly.
Looking at the last year, NXP shows a small growth in Revenue. The Revenue has grown by 5.60% in the last year.
NXP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.33% yearly.
EPS 1Y (TTM)196.15%
EPS 3Y-16.49%
EPS 5Y-6.91%
EPS Q2Q%182%
Revenue 1Y (TTM)5.6%
Revenue growth 3Y42.05%
Revenue growth 5Y24.33%
Sales Q2Q%7.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXP Yearly Revenue VS EstimatesNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.96, which indicates a very decent valuation of NXP.
The average S&P500 Price/Earnings ratio is at 28.04. NXP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.96
Fwd PE N/A
NXP Price Earnings VS Forward Price EarningsNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXP Per share dataNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NXP has a Yearly Dividend Yield of 4.14%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.35, NXP pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

NXP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NXP Yearly Dividends per shareNXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NXP Yearly Income VS Free CF VS DividendNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

More info and screens

NUVEEN SELECT TAX-FREE INC

NYSE:NXP (7/25/2025, 8:11:56 PM)

13.8

+0.04 (+0.29%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-02 2024-12-02
Earnings (Next)N/A N/A
Inst Owners16.67%
Inst Owner Change-0.98%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap701.73M
Analysts45
Price TargetN/A
Short Float %0.12%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date07-15 2025-07-15 (0.052)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.96
Fwd PE N/A
P/S 22.64
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 1.08
EV/EBITDA N/A
EPS(TTM)1.54
EY11.16%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.61
BVpS12.8
TBVpS12.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.28%
ROE 11.52%
ROCE 4.58%
ROIC 3.62%
ROICexc 3.62%
ROICexgc 3.62%
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.18%
OM growth 5Y0.68%
PM growth 3Y-16.4%
PM growth 5Y-7.52%
GM growth 3Y0.36%
GM growth 5Y0.21%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 30.16
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.15%
EPS 3Y-16.49%
EPS 5Y-6.91%
EPS Q2Q%182%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.6%
Revenue growth 3Y42.05%
Revenue growth 5Y24.33%
Sales Q2Q%7.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.14%
EBIT growth 3Y43.71%
EBIT growth 5Y25.17%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A